Clinical Decision Support Systems Market: Impact of Telehealth Integration

The global clinical decision support systems market size was estimated at USD 5.30 billion in 2023 and is projected to grow at a CAGR of 10.79% from 2024 to 2030. Clinical decision support systems (CDSSs) have experienced significant advancement in recent decades, providing clinicians with vital tools to make informed decisions in patient care. These systems have emerged as a promising means to improve patient outcomes and reduce overall healthcare costs.

AI and ML technologies are transforming the CDSS market, offering advanced functionalities such as predictive analytics, pattern recognition, and tailored recommendations. AI-driven CDSSs can analyze extensive datasets, detect patterns, anticipate outcomes, and suggest optimal treatment strategies. Researchers are integrating AI with CDSS, as demonstrated by the University of Texas at Austin’s Dell Medical School researchers who developed an AI-based CDSS to aid clinicians in discussing nutrition and making decisions with patients about diet improvements in December 2022.

Gather more insights about the market drivers, restrains and growth of the Clinical Decision Support Systems Market

Detailed Segmenatation

Product Insights

The standalone CDSS segment held the market with the largest revenue share of over 30.0% in 2023, because it is widely adopted for its low cost and simplicity. They don't require standardization or extensive clinical expertise and can operate without real patient data. Their user-friendly nature contributes to dominance in hospitals and clinical settings.The integrated EHR with CDSS segment is expected to grow at the fastest CAGR during the forecast period, driven by increasing EHR adoption in multi-specialty healthcare facilities.

Delivery Mode Insights

Based on delivery mode, the on premise segment led the market with the largest revenue share of 42.35% in 2023. On-premise CDSS solutions offer flexibility for customization and integration with existing healthcare systems and workflows, catering to specific organizational needs. Multispecialty hospitals and large healthcare organizations prefer this system for greater data control within their infrastructure. Integration with existing systems like EHRs enables smoother data flow and interoperability, enhancing decision support efficiency.

Application Insights

Based on application, the drug allergy alerts segment held the market with the largest revenue share of over 25.0% in 2023, because it is widely utilized in clinical decision support systems (CDSSs) to enhance patient safety and prevent adverse drug reactions (ADRs). CDSSs allow customization of alerts based on individual patient profiles and specific allergy information. Healthcare providers can tailor alert thresholds and preferences to ensure relevance and actionability for each patient. The rising burden of drug allergies is driving CDSS adoption, fueling segment growth. For example, approximately 10% of the U.S. population is allergic to penicillin, according to the CDC.

Component Insights

Based on component, the services segment led the market with the largest revenue share of 42.49% in 2023, offering implementation, training, support, customization, and consulting services to help healthcare organizations maximize CDSS software value and optimize clinical decision-making. This segment dominated the market as continuous technical support ensures CDSS functionality and performance. In addition, healthcare professionals require training to effectively utilize CDSS, further propelling segment growth.

Regional Insights

The clinical decision support systems market in North America accounted for the revenue share of 43.76% in 2023. This dominance is fueled by the rising demand for IT solutions in healthcare and the emphasis on delivering quality healthcare services. Rapid technological advancements further drive market growth. Initiatives promoting CDSS adoption, like EBSCO Information Services' Dyna Innovation Center launch in December 2023, contribute to regional market expansion.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global patient engagement solutions market size was valued at USD 22.7 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 17.7% from 2024 to 2030.

• The healthcare reimbursement market size was valued at USD 21.83 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 18.3% from 2024 to 2030. 

Key Companies profiled:

• McKesson Corporation

• Oracle (Cerner Corporation)

• Siemens Healthineers GmbH

• Allscripts Healthcare, LLC

• athenahealth, Inc.

• NextGen Healthcare Inc.

• Koninklijke Philips N.V.

• IBM

• Agfa-Gevaert Group (IG Farben)

• Wolters Kluwer N.V.

Clinical Decision Support Systems Market Segmentation

Grand View Research has segmented the global clinical decision support systems market report based on product, application, delivery mode, component, and region:

Clinical Decision Support Systems Product Outlook (Revenue, USD Million, 2018 - 2030)

• Standalone CDSS

• Integrated CPOE with CDSS

• Integrated EHR with CDSS

• Integrated CDSS with CPOE & EHR

Clinical Decision Support Systems Application Outlook (Revenue, USD Million, 2018 - 2030)

• Drug-drug interactions

• Drug allergy alerts

• Clinical reminders

• Clinical guidelines

• Drug dosing support

• Others

Clinical Decision Support Systems Delivery Mode Outlook (Revenue, USD Million, 2018 - 2030)

• Web-based Systems

• Cloud-based Systems

• On-premise Systems

Clinical Decision Support Systems Component Outlook (Revenue, USD Million, 2018 - 2030)

• Hardware

• Software

• Services

Order a free sample PDF of the Clinical Decision Support Systems Market Intelligence Study, published by Grand View Research. 

Recent Developments

• In October 2023, Wolters Kluwer Health launched AI Labs, a collective resource to integrate generative AI with UpToDate, its CDS solution, enabling medical professionals to make better-informed decisions

• In August 2023, GE HealthCare launched CardioVisio for Atrial Fibrillation, a patient-centric, digital CDS tool to allow precision care

• In February 2023, EBSCO Information Services launched new features in DynaMedex Mobile App to improve clinical decision support. These enhancements improve the mobile experience for users by enabling clinicians to deliver evidence-based patient care efficiently

• Moreover, in May 2020, DHIndia announced a partnership with EHRC@IIITB & Healthelife to develop a CDSS for the screening of COVID-19. The partnership also included the formation of a minimal triage application for front-line doctors

• In March 2020, IBM Watson Health partnered with EBSCO Information Services to enhance CDSS and operations for healthcare systems and providers